Welcome to Markets Desk, here's what's moving the tape this afternoon.
The Nasdaq one hundred took a severe beating, erasing two point three trillion dollars in market value as a post-midterm sell-off hammered technology names. Bank of America is now stepping in with guidance for investors, urging discipline over reaction and warning against panic-driven repositioning in what remains a volatile sector.
Caught in that same downdraft, AMD shares cratered roughly seventeen percent on the session, closing just above four hundred dollars. For investors who had been watching the stock from the sidelines with a target price in mind, that level has now arrived, raising the question of whether this is a technical entry point or the beginning of a deeper structural repricing.
On a brighter note, Novo Nordisk delivered a strong third-quarter update, with its oral weight-loss pill emerging as the headline driver of the beat. After a prolonged period of pressure on the stock, investors are beginning to ask whether the Danish pharma giant has finally found the catalyst it needs to mount a credible recovery heading into next year.
That's the tape. Markets Desk, signing off the floor.
